ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.00%
S&P ASX All Technology
2,972.40
0.00%
Brent Oil
83.63
0.11%
US Dollar vs AUD
1.52207
-0.58%
Bitcoin
59,348.32
1.92%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Sanofi (SAN)

  7. Sanofi (SAN) News

SAN Sanofi

91.90
-1.18 (-1.27%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sanofi SAN Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-1.18 -1.27% 91.90 01:40:00
Open Price Low Price High Price Close Price Previous Close
93.99 91.33 94.03 91.90 93.08
more quote information »

Recent News

Date Time Source Heading
02/5/202415:00GLOBEPress Release: Beyfortus real-world evidence published in..
01/5/202402:00GLOBEPress Release: Annual General Meeting of April 30, 2024
25/4/202415:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/4/202415:00GLOBECommuniqué de presse : L’étude de phase III LUNA 3 du..
17/4/202415:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
13/4/202404:05GLOBESanofi: Informations relatives au nombre de droits de vote..
09/4/202402:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/3/202417:30GLOBECommuniqué de presse : Mise en ligne du document «Q1 2024..
16/3/202406:04GLOBESanofi: Information concerning the total number of voting..
11/3/202417:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
25/2/202401:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
24/2/202404:45GLOBECommuniqué de presse : Dépôt du Document d’Enregistrement..
23/2/202417:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
23/2/202405:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
21/2/202409:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202417:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
16/2/202400:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/2/202418:00GLOBECommuniqué de presse : Entraide, conditions de travail..
01/2/202417:30GLOBECommunique de presse - 2023 : Croissance des ventes et du..
26/1/202406:30GLOBEPress Release: Dupixent® FDA approved as first and only..
23/1/202422:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202417:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
18/1/202408:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/1/202418:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
09/1/202417:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
21/12/202318:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
21/12/202317:30GLOBEPress Release: Sanofi announces end of program evaluating..
19/12/202323:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202307:59GLOBESanofi: Informations relatives au nombre de droits de vote..
15/12/202317:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
15/12/202317:00GLOBEPress Release: EMA gives positive opinion to Fexinidazole..
12/12/202309:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
12/12/202308:08GLOBECommuniqué de presse : Déclaration au sujet de la..
11/12/202317:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
11/12/202311:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
07/12/202318:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
07/12/202318:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
07/12/202317:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202313:30GLOBECommuniqué de presse : Sanofi sur la voie du leadership..
07/12/202300:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
06/12/202321:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
01/12/202301:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
28/11/202302:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
27/11/202318:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
27/11/202317:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
24/11/202304:00GLOBESanofi: Information concerning the total number of voting..
08/11/202300:56DJNSanofi Under Preliminary Probe in France Over Possible..
30/10/202323:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
28/10/202302:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
27/10/202319:43DJNSanofi Shares Tumble After Warning of Profit Hit From..

Your Recent History

EU
SAN
Sanofi
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved